Healthcare

Assessing Market Opportunities for 12 Targeted Drugs Categories for Financial Investment 对投资目标(12种药物)的市场潜力进行尽职调查

客户想要对包含12种药物的目标进行投资,因此寻求我们帮助他们对收购目标进行商业尽职调查,以了解调查目标的销售及增长预期,同时也对每种药物的主要的竞争对手进行了调查。

Background

Our client was evaluating a potential target in China for investment. To support this objective, SmithStreet conducted an engagement to assist our client in commercial due diligence on this target (12 drugs) to understand targeted drugs’ sales and projected growth, as well as identify the major competitors’ market landscape


Solutions

•    Understood China healthcare reforms at macro-level and the winning levers for pharmaceutical companies

•    Analyzed the historical sales value, volume and performance for each drug, their competitors and drug categories over the past 5 years. Sales value were based on ex-manufacture price and hospital purchasing price respectively

•    Assessed the drugs’ market acceptance and popularity at doctor / hospital level, including the pipeline drugs’ market potential and how marketing initiatives would impact sales

•    Evaluated the potential market sizing through mapping out a patient flow for each drug over the next 5 years


Methodology

•    Approximately, 40 in-depth interviews with stakeholders in the value chain, including Chief/Vice-Chief physicians in Tier 1&2 cities, Brand sales personnel and distributors

•    5 years’ ex-manufacture sales value and volume 


Selected Findings



RELATED STORIES

Mapping Out Hematology Lab Market in China’s Tier 1 & 2 Cities Regardin...
The client, a leading medical device manufacturer, wanted to know the market size and market potential for its capital e...
more
Developing “5-Year Go-to-Market” Strategy by Accessing China Market Po...
The client, a leading medical manufacturer, wanted to know how to leverage key strategies to seize opportunities for its...
more
Development of China's ICL Market for Medical Testing 全国第三方医学检验...
Currently, there are about 440 ICL companies with 680 labs/locations. There are in total 27 ICL chains with 250 labs; th...
more
LoginNot a registered user? Register now.
E-mail
Password
Remember me

Login using your social network

RegisterAlready registered? Login now.

SmithStreet provides you source for today’s leading business ideas. Our content explores the topics critical to China market today.

Create your SmithStreet account:

E-mail address & password

*E-mail
Make sure you typed it correctly.
*Password
Make it 6-10 characters, no spaces
*Confirm Password

Personal Information

*First Name
*Last Name
Company
Job Title
Job Function
Country
Screen Name

Subscribe

Subscribe to our China Spotlight weekly news feed - a complimentary email newsletter that matters to your China strategy.

Healthcare

Consumers and Retail

I agree with the Legal Terms.
RegisterAlready registered?

Create your SmithStreet account:

*E-mail
Make sure you typed it correctly.
*Password
Make it 6-10 characters, no spaces
*Confirm Password

Personal Information

*First Name
*Last Name
Company
Job Title
Job Function
Country
Screen Name
Legal Terms
This is the official privacy policy for www.smithstreetchina.com, which is administered, owned and operated by SmithStreet. This policy is intended to provide you with important information regarding your use of the Site.

This Site is owned, operated and targeted for use in China and may not comply with other nation’s laws or regulations. Your continued use of this Site implies your acceptance of our policies and practices as described below.

We do not collect any personally identifiable information from visitors to the site unless they voluntarily submit information.

You may choose to subscribe to our email edition, which requires you to submit a valid email address. This service is operated for free on an opt-in basis, and you may unsubscribe at any time by emailing info@smithstreetsolutions.com.

The information we collect is used for internal review and is then discarded, used to improve the content of our website page.

We do not set any cookies.

If you do not want to receive e-mail from us in the future, please let us know by sending us e-mail at the above address.

All of the content posted on our Site is created in-house. We do summarize news from other resources by following fair convention. If, for any reason, you would like us to remove any content, graphics, or other information that you consider a breach of copyright law, please email us, or feel free to call us by below number.

We reserve the right to revise this policy at any time. Revisions will be posted in this location. Any and all posted revisions are effective immediately. Please check back often to stay informed about your use of the Site.

Please contact us directly if you have any questions about this Policy or anything else.

Email: info@smithstreetsolutions.com
Tel: (8621) 6565 6533

This Policy was last modified on November 1st, 2013 and is effective immediately.